Last reviewed · How we verify
NCT06992206: Kidney stone
What Lies Beneath the Stone? Metabolic Insights From Composition-Based Analysis of Kidney Stones
trial testing Metabolik taş analizi ile retrospektif gözlem in Urolithiasis, Calcium Oxalate in 506 participants. Completed in 31 December 2024.
31 December 2024
Quick facts
| Lead sponsor | Hisar Intercontinental Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 506 |
| Start date | 1 January 2010 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2024 |
Drugs / interventions tested
- Metabolik taş analizi ile retrospektif gözlem
Conditions studied
- Urolithiasis, Calcium Oxalate — all drugs for Urolithiasis, Calcium Oxalate →
Sponsor
Hisar Intercontinental Hospital
Who can join
Adults 18 to 80, any sex, with Urolithiasis, Calcium Oxalate. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This retrospective observational study investigates the metabolic abnormalities associated with different types of kidney stones by analyzing their composition. The study includes adult patients diagnosed with urolithiasis, whose stone samples were analyzed using Fourier Transform Infrared (FTIR) spectroscopy. Clinical, biochemical, and 24-hour urine metabolic parameters were compared between first-time and recurrent stone formers, and among subtypes of calcium oxalate stones (monohydrate vs. dihydrate). The goal is to identify metabolic risk factors that contribute to stone formation and recurrence, and to provide insights for individualized prevention strategies.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06992206
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Urolithiasis, Calcium Oxalate
Currently open trials in the same condition.
- NCT07071948 — A Single-Center Clinical Study on the Efficacy and Safety of VISOR · NA · recruiting
- NCT06989320 — Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease · NA · recruiting
- NCT06331546 — Gut Oxalate Absorption in Calcium Oxalate Stone Disease · NA · recruiting
- NCT06330246 — O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease · NA · recruiting
Other Hisar Intercontinental Hospital trials
Trials by the same sponsor.
- NCT07260201 — Triglyceride-Glucose and TGI-BMI Indices Compared With HOMA-IR · completed
- NCT06584981 — Effect of PECS II, Parasternal and Serratus Plane Blocks on Postoperative Pain in MIDCAB Surgery · NA · completed
- NCT06459713 — Multiplex Respiratory PCR Results in Diabetic Pneumonia Cases · completed
- NCT05175027 — Preoperative Antiseptic in Newborn Circumcision Comparison of Povidone Iodine and Hypochlorous Acid Used · NA · completed
- NCT06257654 — One-year Results After Single-center Water Vapor Thermal Therapy for Symptomatic Benign Prostatic Hyperplasia. · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06992206 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hisar Intercontinental Hospital
- Last refreshed: 28 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06992206.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing